Ownership history in PERCEPTIVE ADVISORS LLC · 10 quarters on record
This page tracks every 13F SEC filing in which PERCEPTIVE ADVISORS LLC reported a position in APOGEE THERAPEUTICS INC (APGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 2,330,651 | +978,662 | +72.4% | 3.14% | $175.9M | $75.48 |
| 2025 Q3 | ADDED | 1,351,989 | +169,841 | +14.4% | 1.55% | $53.7M | $39.73 |
| 2025 Q2 | ADDED | 1,182,148 | +59,381 | +5.3% | 1.90% | $51.3M | $43.43 |
| 2025 Q1 | ADDED | 1,122,767 | +75,535 | +7.2% | 1.48% | $41.9M | $37.36 |
| 2024 Q4 | REDUCED | 1,047,232 | -967,775 | -48.0% | 1.31% | $47.4M | $45.30 |
| 2024 Q3 | REDUCED | 2,015,007 | -90,629 | -4.3% | 2.50% | $118.4M | $58.74 |
| 2024 Q2 | REDUCED | 2,105,636 | -593,709 | -22.0% | 1.97% | $82.9M | $39.35 |
| 2024 Q1 | ADDED | 2,699,345 | +871,444 | +47.7% | 3.12% | $179.4M | $66.45 |
| 2023 Q4 | UNCHANGED | 1,827,901 | — | 0% | 1.14% | $51.1M | $27.94 |
| 2023 Q3 | INITIATED | 1,827,901 | — | — | 1.30% | $38.9M | — |
As of 2025 Q4 — sorted by position size